FIL Ltd
Insider CIK 318989 · IRWD 10% owner · UMRX · DNLI · SURF · XLO · GPCR · BCAX
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BCAX Bicara Therapeutics Inc. | C Conversion deriv | 2024-09-16 | 2024-09-18 | 352,876 | — | $0 | 0 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion deriv | 2024-09-16 | 2024-09-18 | 54,092 | — | $0 | 0 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion deriv | 2024-09-16 | 2024-09-18 | 606,885 | — | $0 | 0 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion | 2024-09-16 | 2024-09-18 | 54,092 | — | $0 | 54,092 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion | 2024-09-16 | 2024-09-18 | 606,885 | — | $0 | 660,977 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion | 2024-09-16 | 2024-09-18 | 352,876 | — | $0 | 1,013,853 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion deriv | 2023-02-07 | 2023-02-09 | 4,013,678 | — | $0 | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion deriv | 2023-02-07 | 2023-02-09 | 620,499 | — | $0 | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion deriv | 2023-02-07 | 2023-02-09 | 452,867 | — | $0 | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion deriv | 2023-02-07 | 2023-02-09 | 179,242 | — | $0 | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion deriv | 2023-02-07 | 2023-02-09 | 71,636 | — | $0 | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion deriv | 2023-02-07 | 2023-02-09 | 10,154 | — | $0 | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion deriv | 2023-02-07 | 2023-02-09 | 7,411 | — | $0 | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion deriv | 2023-02-07 | 2023-02-09 | 494,035 | — | $0 | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion deriv | 2023-02-07 | 2023-02-09 | 624,239 | — | $0 | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion | 2023-02-07 | 2023-02-09 | 494,035 | — | $0 | 494,035 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion | 2023-02-07 | 2023-02-09 | 624,239 | — | $0 | 624,239 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion | 2023-02-07 | 2023-02-09 | 452,867 | — | $0 | 5,087,044 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion | 2023-02-07 | 2023-02-09 | 7,411 | — | $0 | 89,201 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion | 2023-02-07 | 2023-02-09 | 10,154 | — | $0 | 81,790 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion | 2023-02-07 | 2023-02-09 | 71,636 | — | $0 | 71,636 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion | 2023-02-07 | 2023-02-09 | 179,242 | — | $0 | 5,266,286 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion | 2023-02-07 | 2023-02-09 | 620,499 | — | $0 | 4,634,177 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion | 2023-02-07 | 2023-02-09 | 4,013,678 | — | $0 | 4,013,678 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion deriv | 2021-10-26 | 2021-10-28 | 2,077,698 | — | $0 | 0 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion | 2021-10-26 | 2021-10-28 | 218,705 | — | $0 | 218,705 | SEC↗ |
| SURF Surface Oncology, Inc. | C Conversion deriv | 2018-04-23 | 2018-04-25 | 1,950,777 | — | $0 | 0 | SEC↗ |
| SURF Surface Oncology, Inc. | C Conversion | 2018-04-23 | 2018-04-25 | 886,716 | — | $0 | 886,716 | SEC↗ |
| UMRX Unum Therapeutics Inc. | C Conversion deriv | 2018-04-03 | 2018-04-05 | 42,931 | — | $0 | 0 | SEC↗ |
| UMRX Unum Therapeutics Inc. | C Conversion deriv | 2018-04-03 | 2018-04-05 | 1,744,310 | — | $0 | 0 | SEC↗ |
| UMRX Unum Therapeutics Inc. | C Conversion | 2018-04-03 | 2018-04-05 | 27,342 | — | $0 | 1,138,274 | SEC↗ |
| UMRX Unum Therapeutics Inc. | C Conversion | 2018-04-03 | 2018-04-05 | 1,110,932 | — | $0 | 1,110,932 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 292,303 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 1,397,326 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 51 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 34 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 193 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 15,021 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 15,068 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 54,854 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 71,875 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 20 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 13 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 77 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 6,008 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 6,027 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 21,942 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 28,750 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 1,008 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 662 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 3,755 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 1,065,616 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 293,204 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 292,303 | — | $0 | 379,427 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 15,068 | — | $0 | 401,692 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 6,008 | — | $0 | 385,435 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 6,027 | — | $0 | 386,624 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 293,204 | — | $0 | 380,597 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 54,854 | — | $0 | 1,460,570 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 21,942 | — | $0 | 1,405,716 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 1,065,616 | — | $0 | 1,383,774 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 71,875 | — | $0 | 1,914,833 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 28,750 | — | $0 | 1,842,958 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 1,397,326 | — | $0 | 1,814,208 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 51 | — | $0 | 1,379 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 20 | — | $0 | 1,328 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 1,008 | — | $0 | 1,308 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 34 | — | $0 | 906 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 13 | — | $0 | 872 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 662 | — | $0 | 859 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 193 | — | $0 | 5,146 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 77 | — | $0 | 4,953 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 3,755 | — | $0 | 4,876 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 15,021 | — | $0 | 400,456 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2013-03-28 | 2013-04-02 | 158,068 | $18.40 | $2.91M | 837,736 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2013-03-21 | 2013-03-25 | 240,100 | — | $0 | 995,804 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-10-15 | 2012-10-15 | 35,153 | $13.13 | $461.6K | 1,235,904 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-10-12 | 2012-10-15 | 118,220 | $13.37 | $1.58M | 1,271,057 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-10-11 | 2012-10-15 | 59,502 | $13.08 | $778.3K | 1,389,277 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-10-08 | 2012-10-09 | 5,878 | $13.00 | $76.4K | 1,448,779 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-10-05 | 2012-10-09 | 12,727 | $13.02 | $165.7K | 1,454,657 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-10-04 | 2012-10-09 | 700 | $13.00 | $9.1K | 1,467,384 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-10-03 | 2012-10-03 | 6,300 | $13.00 | $81.9K | 1,468,084 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-10-01 | 2012-10-03 | 2,100 | $13.02 | $27.3K | 1,474,384 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-09-27 | 2012-09-28 | 43,622 | $13.24 | $577.6K | 1,476,484 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-09-26 | 2012-09-28 | 51,073 | $13.20 | $674.2K | 1,520,106 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-09-25 | 2012-09-25 | 36,056 | $13.88 | $500.5K | 1,571,179 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-09-24 | 2012-09-25 | 80,409 | $14.09 | $1.13M | 1,607,235 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-09-21 | 2012-09-25 | 119,221 | $14.89 | $1.78M | 1,806,865 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-09-20 | 2012-09-20 | 53,342 | $13.75 | $733.5K | 1,806,865 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-09-19 | 2012-09-20 | 55,878 | $13.34 | $745.4K | 1,860,207 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-09-18 | 2012-09-20 | 49,113 | $13.53 | $664.5K | 1,916,085 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-09-17 | 2012-09-17 | 39,337 | $13.22 | $520.0K | 1,965,198 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-09-14 | 2012-09-17 | 84,925 | $13.14 | $1.12M | 2,004,535 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-09-13 | 2012-09-17 | 29,514 | $13.06 | $385.5K | 2,089,460 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-08-30 | 2012-09-04 | 24,100 | $13.16 | $317.2K | 2,118,974 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-07-31 | 2012-08-01 | 5,345 | $13.09 | $70.0K | 2,143,074 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-07-30 | 2012-08-01 | 2,100 | $13.26 | $27.8K | 2,148,419 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-07-27 | 2012-07-30 | 41,419 | $13.38 | $554.2K | 2,150,519 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-07-26 | 2012-07-30 | 17,261 | $13.07 | $225.6K | 2,191,938 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-07-25 | 2012-07-30 | 200 | $13.00 | $2.6K | 2,209,199 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-07-24 | 2012-07-24 | 6,900 | $13.01 | $89.8K | 2,209,399 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-07-20 | 2012-07-24 | 16,040 | $13.08 | $209.8K | 2,216,299 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-07-19 | 2012-07-20 | 47,252 | $13.35 | $630.8K | 2,232,363 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-07-18 | 2012-07-20 | 18,060 | $13.40 | $242.0K | 2,279,615 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-07-17 | 2012-07-20 | 7,903 | $13.63 | $107.7K | 2,297,675 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-07-16 | 2012-07-16 | 14,708 | $13.80 | $203.0K | 2,305,578 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-07-13 | 2012-07-16 | 20,005 | $13.78 | $275.7K | 2,320,286 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-07-12 | 2012-07-16 | 600 | $13.33 | $8.0K | 2,340,291 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-07-06 | 2012-07-06 | 18,065 | $13.90 | $251.1K | 2,359,846 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-07-05 | 2012-07-06 | 16,960 | $14.00 | $237.4K | 2,377,911 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-07-03 | 2012-07-06 | 9,392 | $13.96 | $131.1K | 2,394,871 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-07-02 | 2012-07-02 | 14,700 | $13.92 | $204.6K | 2,404,263 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-06-29 | 2012-07-02 | 36,600 | $13.77 | $504.0K | 2,418,963 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2012-06-28 | 2012-07-02 | 5,274 | $13.94 | $73.5K | 2,455,563 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | G Gift | 2012-03-15 | 2012-03-16 | 1,225,178 | — | $0 | 2,460,837 | SEC↗ |